Metraipolis › archive › dc_43fbee8adeb1
High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden — Europe PMC PMID:37578904
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/37578904
- DOI
- 10.1289/ehp11847
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-07T12:29:08.920Z
- SHA-256 of the archived text
d15943ba39cc6416e32cd73ca0d0ba5fea45a99abad8789401e70c779473a359- Stable URL of this page
https://metraipolis.com/documento/dc_43fbee8adeb1
How to cite
High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden — Europe PMC PMID:37578904 — Europe PMC (en), https://europepmc.org/article/MED/37578904 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_43fbee8adeb1 (Metraipolis archive dc_43fbee8adeb1, sha256 d15943ba39cc6416e32cd73ca0d0ba5fea45a99abad8789401e70c779473a359)
BibTeX
@misc{dc43fbee8adeb1,
title = {High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden — Europe PMC PMID:37578904},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/37578904},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_43fbee8adeb1; sha256 d15943ba39cc6416e32cd73ca0d0ba5fea45a99abad8789401e70c779473a359},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37578904. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Per- and polyfluoroalkyl substances (PFAS) are widely used, environmentally ubiquitous, and stable chemicals that have been associated with lower vaccine-induced antibody responses in children; however, data on adults are limited. The drinking water from one of the two waterworks in Ronneby, Sweden, was heavily contaminated for decades with PFAS from firefighting foams, primarily perfluorohexane sulfonic acid and perfluorooctanesulfonic acid (PFOS). Vaccination against SARS-CoV-2 offered a unique opportunity to investigate antibody responses to primary vaccination in adults who had been exposed to PFAS. Objectives: Our objective was to evaluate associations between PFAS, across a wide range of exposure levels, and antibody responses in adults 5 wk and 6 months after a two-dose vaccination regime against SARS-CoV-2. Methods: Adults age 20-60 y from Ronneby (n=309, median PFOS serum level 47 ng/mL, fifth to 95th percentile 4-213 ng/mL) and a group with background exposure (n=47, median PFOS serum level 4 ng/mL) received two doses of the Spikevax (Moderna) mRNA vaccine. The levels of seven PFAS were measured in serum before vaccination. Serum immunoglobulin G antibodies against the SARS-CoV-2 spike antigen (S-Abs) were measured before vaccination and at 5 wk (n=350) and 6 months (n=329) after the second vaccine dose. Linear regression analyses were fitted against current, historical, and prenatal exposure to PFAS, adjusting for sex, age, and smoking, excluding individuals with previous SARS-CoV-2-infection. Results: PFAS exposure, regardless of how it was estimated, was not negatively associated with antibody levels 5 wk [current PFOS: -0.5% S-Abs/PFOS interquartile range (IQR); 95% confidence interval (CI): -8, 7] or 6 months (current PFOS: 3% S-Abs/PFOS IQR; 95% CI: -6, 12) after COVID-19 vaccination. Discussion: Following a strict study protocol, rigorous study design, and few dropouts, we found no indication that PFAS exposure negatively affected antibody responses to COVID-19 mRNA vaccination for up to 6 months after vaccination. https://doi.org/10.1289/EHP11847. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2023 (prima pubblicazione 2023-08-14). Identificativi: PMID 37578904 · PMCID PMC10424820 · DOI 10.1289/ehp11847. Descrittori MeSH principali: Alkanesulfonic Acids; Fluorocarbons; Vaccines; COVID-19. Pagina: https://europepmc.org/article/MED/37578904 — https://doi.org/10.1289/ehp11847. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-07T12:01:43.205Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.